Active Marketing Authorisations for Immediate Licensing

Explore Vyocure’s portfolio of active Marketing Authorisations (MAs) across regulated and emerging markets. Each MA is backed by robust supply agreements and proven regulatory success.

Request a consultation

Explore the MA-List

Vyocure’s Active Marketing Authorisations

Our Marketing Authorisations (MAs) span a wide range of high-demand pharmaceutical products. Each dossier has completed national or decentralized procedures and is available for licensing in selected markets. Contact us for specific country availability or dossier documentation.

Ceftriaxone Vial 1.0g/2.0g

Procedure: National Procedure Completed
MA Status: Active – United Kingdom
Markets: Inquire

Ceftriaxone Vial 0.25g / 0.5g / 1.0g / 2.0g

Procedure: DCP Procedure Completed
MA Status: Active – European Union
Markets: Inquire

Ceftazidime Vial 0.5g / 1.0g / 2.0g

Procedure: DCP Procedure Completed
MA Status: Active – European Union
Markets: Inquire

Cefazolin Vial 1.0g / 2.0g

Procedure: DCP Procedure Completed
MA Status: Active – European Union
Markets: Inquire

Cefotaxime Vial 0.5g / 1.0g / 2.0g

Procedure: DCP Procedure Completed
MA Status: Active – European Union
Markets: Inquire

Cefuroxime Vial 0.75g / 1.5g

Procedure: DCP Procedure Completed
MA Status: Active – European Union
Markets: Inquire

Rubrik (20)

Looking for a specific dossier?

Our dossier portfolio includes over 200 CTD-formatted dossiers across all major therapeutic areas and dosage forms. If you're searching for a specific product or need tailored documentation, our regulatory team is here to assist.

Request dossier info

Inquire about availability